A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37

Clinical Breast Cancer

Volumn 8, Issue 3, 2008, Pages 287-292

  Wapnir, Irene L ^a,b   Aebi, Stefan ^c,d   Geyer, Charles E ^a,e   Zahrieh, David ^c,f   Gelber, Richard D ^c,f   Anderson, Stewart J ^a,g   Robidoux, André ^a,h   Bernhard, Jürg ^c   Maibach, Rudolf ^c   Castiglione Gertsch, Monica ^c   Coates, Alan S ^c,i   Piccart, Martine J ^j,k   Clemons, Mark J ^a,l   Costantino, Joseph E ^a,g   Wolmark, Norman ^a,e  

^a NSABP Foundation Inc   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c International Breast Cancer Study Group   (Switzerland)

^d UNIVERSITY OF BERN   (Switzerland)

^e ALLEGHENY GENERAL HOSPITAL   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^h CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

ⁱ UNIVERSITY OF SYDNEY   (Australia)

^j JULES BORDET INSTITUTE   (Belgium)

^k Breast International Group   (Belgium)

^l PRINCESS MARGARET HOSPITAL   (Canada)

more..

Author keywords

Ipsilateral breast cancer; Radiation therapy; Recurrence

Indexed keywords

ALKYLATING AGENT; ALPHA INTERFERON; ANTHRACYCLINE DERIVATIVE; AROMATASE INHIBITOR; DACTINOMYCIN; DOXORUBICIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAMOXIFEN; TAXANE DERIVATIVE; TRASTUZUMAB;

BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; MULTICENTER STUDY; OVERALL SURVIVAL; PHASE 3 CLINICAL TRIAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

EID: 46949089752     PISSN: 15268209     EISSN: None     Source Type: Journal    
DOI: 10.3816/CBC.2008.n.035     Document Type: Article

References (40)

1. Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355:1757-70.
2. Waeber M, Castiglione-Gertsch M, Dietrich D, et al. Adjuvant therapy after excision and radiation of isolated postmastectomy locoregional breast cancer recurrence: definitive results of a phase III randomized trial (SAKK 23/82) comparing tamoxifen with observation. Ann Oncol 2003; 14:1215-21.
3. Andry G, Suciu S, Vico P, et al. Locoregional recurrences after 649 modified radical mastectomies: incidence and significance. Eur J Surg Oncol 1989; 15:476-85.
4. Arriagada R, Lê MG, Contesso G, et al. Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 2007; 13:1404-13.
5. Fisher B, Anderson S, Wickerham DL, et al. Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22. J Clin Oncol 1997; 15:1858-69.
6. Schmoor C, Sauerbrei W, Bastert G, et al. Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. J Clin Oncol 2000; 18:1696-708.
7. Clemons M, Danson S, Hamilton T, et al. Locoregionally recurrent breast cancer: incidence, risk factors and survival. Cancer Treat Rev 2001; 27:67-82.
8. Taghian A, Jeong JH, Mamounas E, et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 2004; 22:4247-54.
9. Wapnir IL, Anderson SJ, Mamounas EP, et al. Prognosis after ipsi-lateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006; 24:2028-37.
10. Brunner KW, Harder F, Greiner R, et al. Loco-regional recurrence following surgery of breast carcinoma: prognostic factors and therapeutic consequences [in German]. Schweiz Med Wockensckr 1988; 118:1976-81.
11. Schwaibold F, Fowble BL, Solin LJ, et al. The results of radiation therapy for isolated local regional recurrence after mastectomy. Int J Radiat Oncol Biol Pkys 1991; 21:299-310.
12. Willner J, Kiricuta IC, Kolbl O. Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1997; 37:853-63.
13. Kamby C, Sengelov L. Pattern of dissemination and survival following isolated locoregional recurrence of breast cancer. A prospective study with more than 10 years of follow up. Breast Cancer Res Treat 1997; 45:181-92.
14. Stotter A, Atkinson EN, Fairston BA, et al. Survival following locoregional recurrence after breast conservation therapy for cancer. Ann Surg 1990; 212:166-72.
15. Fowble B, Solin LJ, Schultz DJ, et al. Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment. Int J Radiat Oncol Biol Phys 1990; 19:833-42.
16. Haffty BG, Fischer D, Beinfield M, et al. Prognosis following local recurrence in the conservatively treated breast cancer patient. Int J Radiat Oncol Biol Phys 1991; 21:293-8.
17. Halverson KJ, Perez CA, Kuske RR, et al. Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis. Int J Radiat Oncol Biol Phys 1992; 23:285-91.
18. Abner AL, Recht A, Eberlein T, et al. Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer. J Clin Oncol 1993; 11:44-8.
19. Cajucom CC, Tsangaris TN, Nemoto T, et al. Results of salvage mastectomy for local recurrence after breast-conserving surgery without radiation therapy. Cancer 1993; 71:1774-9.
20. Leborgne F, Leborgne JH, Ortega B, et al. Breast conservation treatment of early stage breast cancer: patterns of failure. Int J Radiat Oncol Biol Phys 1995; 31:765-75.
21. Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol 1996; 14:52-7.
22. Dalberg K, Mattsson A, Sandelin K, et al. Outcome of treatment for ipsilateral breast tumor recurrence in early-stage breast cancer. Breast Cancer Res Treat 1998; 49:69-78.
23. Doyle T, Schultz DJ, Peters C, et al. Long-term results of local recurrence after breast conservation treatment for invasive breast cancer. Int J Radiat Oncol Biol Phys 2001; 51:74-80.
24. Aberizk WJ, Silver B, Henderson IC, et al. The use of radiotherapy for treatment of isolated locoregional recurrence of breast carcinoma after mastectomy. Cancer 1986; 58:1214-8.
25. Voogd AC, van Oost FJ, Rutgers EJ, et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. Eur J Cancer 2005; 41:2637-44.
26. Wallgren A, Bonett M, Gelber R, et al. Risk factors for locoregional recurrence among breast cancer patients: results from International Breast Cancer Study Group Trials I through VII. J Clin Oncol 2003; 21:1205-13.
27. Early Breast Cancer Trialists' Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005; 365:1687-717.
28. Buzdar AU, Blumenschein GR, Smith TL, et al. Adjuvant chemoim-munotherapy following regional therapy for isolated recurrences of breast cancer (stage IV NED). J Surg Oncol 1979; 12:27-40.
29. Beck TM, Hart NE, Woodard DA, et al. Local or regionally recurrent carcinoma of the breast: results of therapy in 121 patients. J Clin Oncol 1983; 1:400-5.
30. Halverson KJ, Perez CA, Kuske RR, et al. Locoregional recurrence of breast cancer: a retrospective comparison of irradiation alone versus irradiation and systemic therapy. Am J Clin Oncol 1992; 15:93-101.
31. Janjan NA, McNeese MD, Buzdar AU, et al. Management of locoregional recurrent breast cancer. Cancer 1986; 58:1552-6.
32. Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol 1994; 12:2071-7.
33. Fentiman IS, Balkwill FR, Cuzick J, et al. A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence. Eur J Surg Oncol 1987; 13:425-8.
34. Olson CE, Ansfield FJ, Richards MJ, et al. Review of local soft tissue recurrence of breast cancer irradiated with and without actinomycin-D. Cancer 1977; 39:1981-3.
35. Rauschecker H, Clarke M, Gatzemeier W, et al. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev 2007; (4):CD002195.
36. Hurny C, van Wegberg B, Bacchi M, et al. Subjective health estimations (SHE) in patients with advanced breast cancer: an adapted utility concept for clinical trials. Br J Cancer 1998; 77:985-91.
37. Bernhard J, Hurny C, Coates AS, et al. Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. Ann Oncol 1997; 8:825-35.
38. Bernhard J, Sullivan M, Hurny C, et al. M. Clinical relevance of single item quality of life indicators in cancer clinical trials. Br J Cancer 2001; 84:1156-65.
39. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-81.
40. Cox DR. Regression models and life-tables (with discussion). J R Stat Soc B (Methodology) 1972; 34:187-220.